Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,356 | 72 | 69.2% |
| Consulting Fee | $1,050 | 2 | 30.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $1,050 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $803.68 | 18 | $0 (2024) |
| PFIZER INC. | $323.46 | 7 | $0 (2024) |
| ABBVIE INC. | $283.62 | 5 | $0 (2024) |
| Abbott Laboratories | $179.28 | 3 | $0 (2024) |
| Novo Nordisk Inc | $121.11 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $97.78 | 7 | $0 (2023) |
| Amgen Inc. | $97.30 | 2 | $0 (2021) |
| Intuity Medical Inc | $94.97 | 1 | $0 (2022) |
| Daiichi Sankyo Inc. | $71.07 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $765.73 | 26 | AstraZeneca Pharmaceuticals LP ($371.97) |
| 2023 | $517.74 | 19 | AstraZeneca Pharmaceuticals LP ($159.54) |
| 2022 | $1,349 | 10 | Regeneron Pharmaceuticals, Inc. ($1,050) |
| 2021 | $104.66 | 7 | GlaxoSmithKline, LLC. ($55.91) |
| 2020 | $202.07 | 7 | AstraZeneca Pharmaceuticals LP ($120.47) |
| 2019 | $139.55 | 2 | PFIZER INC. ($124.56) |
| 2018 | $83.44 | 1 | Amgen Inc. ($83.44) |
| 2017 | $243.84 | 2 | AstraZeneca Pharmaceuticals LP ($123.84) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Diagnostics | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Womens Health | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $117.03 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: VACCINE | ||||||
| 06/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Womens Health | ||||||
| 06/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Obesity | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $103.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA, AIRSUPRA | Food and Beverage | In-kind items and services | $47.35 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Diabetes Care | ||||||
| 03/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 01/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,161 | 2,447 | $761,507 | $93,251 |
| 2022 | 16 | 2,027 | 2,286 | $683,355 | $86,517 |
| 2021 | 17 | 1,713 | 2,026 | $651,265 | $111,485 |
| 2020 | 18 | 1,672 | 1,999 | $315,525 | $117,094 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 404 | $161,544 | $18,820 | 11.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 281 | 281 | $101,503 | $13,571 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 254 | $143,062 | $13,175 | 9.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 114 | 115 | $32,200 | $8,115 | 25.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 281 | 281 | $23,649 | $5,809 | 24.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 270 | 270 | $22,728 | $5,621 | 24.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $19,295 | $4,799 | 24.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 27 | 27 | $19,755 | $4,696 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 289 | 289 | $166,145 | $4,454 | 2.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 119 | 120 | $12,549 | $4,076 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 260 | 271 | $18,242 | $2,759 | 15.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $16,024 | $2,119 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $10,222 | $1,861 | 18.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $5,874 | $1,439 | 24.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $2,884 | $951.16 | 33.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 18 | $4,194 | $741.12 | 17.7% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 25 | 25 | $1,637 | $244.34 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 338 | $135,486 | $16,239 | 12.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 258 | 258 | $94,254 | $13,231 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 241 | $135,511 | $12,731 | 9.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 116 | 116 | $28,304 | $7,882 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 288 | 288 | $165,754 | $6,744 | 4.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 275 | 275 | $23,121 | $5,874 | 25.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 268 | 268 | $22,794 | $5,809 | 25.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 124 | 124 | $12,772 | $4,144 | 32.4% |
About Dr. Douglas Ashinsky, MD
Dr. Douglas Ashinsky, MD is a Internal Medicine healthcare provider based in Warren, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932175361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Ashinsky, MD has received a total of $3,406 in payments from pharmaceutical and medical device companies, with $765.73 received in 2024. These payments were reported across 74 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,356).
As a Medicare-enrolled provider, Ashinsky has provided services to 7,573 Medicare beneficiaries, totaling 8,758 services with total Medicare billing of $408,347. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Warren, NJ
- Active Since 02/25/2006
- Last Updated 04/06/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932175361
Products in Payments
- FARXIGA (Drug) $564.73
- AIRSUPRA (Drug) $147.03
- FREESTYLE LIBRE (Device) $136.28
- QULIPTA (Drug) $135.47
- UBRELVY (Drug) $135.00
- PREVNAR - 13 (Biological) $124.56
- TRUMENBA (Biological) $120.00
- Pogo Automatic Blood Glucose Monitoring System (Device) $94.97
- BREZTRI (Drug) $91.92
- Ozempic (Drug) $89.79
- NUCALA (Biological) $83.39
- INJECTAFER (Drug) $71.07
- Mirena (Drug) $51.01
- MOUNJARO (Drug) $50.19
- PREVNAR 20 (Biological) $33.91
- PAXLOVID (Drug) $30.01
- FREESTYLE LIBRE 3 (Device) $21.85
- FREESTYLE LIBRE 2 (Device) $21.15
- (8874) inCourage (Device) $19.89
- APTIMA (Device) $19.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Warren
Dr. Thong Truong, Md, MD
Internal Medicine — Payments: $24,467
Rana Bilbeisi, D.o, D.O
Internal Medicine — Payments: $24,199
Jessie Alperin, M.d, M.D
Internal Medicine — Payments: $20,857
Dr. John Weippert, D.o, D.O
Internal Medicine — Payments: $20,569
Dr. Nitin Patel, Md, MD
Internal Medicine — Payments: $15,882
Dr. Badi Altawil, Md, MD
Internal Medicine — Payments: $15,752